Publication | Open Access

Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer

UrologyCancer ImmunosurveillanceSalvage RadiotherapyMedicineImmunologyTherapeutic VaccineImmune Checkpoint InhibitorPhase I/ii TrialProstatic DiseaseImmunotherapyOncologyRadiation Oncology